Care Diagnosis Bladder cancer
Endoscopic Biophotonic Imaging of Bladder Cancer
situ diagnosis of bladder cancer
care diagnostics of bladder cancer
cost-effective optical methods
optical coherence tomography
high-speed imaging systems
superior sensitivity
specificity
novel imaging platform
Point
MIB technology
clinical end-users
MIB objective
functional information
step-change
clinical use
unique imaging fibre bundles
terms of treatment costs
molecular tissue information
real-time capture of unprecedented biomedical information
strong partnership
innovative SMEs
combination of non-invasive
recurrence rates
follow-up procedures
Current unmet clinical needs
hybrid concept
leading market positions
improved diagnostic procedures
healthcare cost savings
earlier onset of effective treatment
world-leading academic organisations
multi-spectral opto-acoustic tomography
excitation Raman difference spectroscopy
multiphoton microscopy
development of new light sources
medical devices
days of hospitalisation
oncology
areas
expensive diseases
prognosis
consortium
endoscopes
European industry
patient quality of life
project
impact
order
commercialization
hypothesis